China' s demand for Alzheimer Disease Drugs has grown at a fast pace in the
past decade. In the next five years, both production and demand will continue
to grow. This new study examines China' s economic trends, investment
environment, industry development, supply and demand, industry capacity,
industry structure, marketing channels and major industry participants.
Historical data (1998, 2003 and 2008) and long-term forecasts throught 2013
and 2018 are presented. Major producers in China are profiled.
Table of Contents
I.INTRODUCTION
Report Scope and Methodology
Executive Summary
II.BUSINESS ENVIRONMENT
Economic Outlook
Key Economic Indicators
Industrial Output
Population and Labor
Foreign Investment
Foreign Trade
Financial and Tax Regulations
Banking System and Regulations
Foreign Exchange
Taxes, Tariff and Custom Duties
III.ALZHEIMER' S DISEASE DRUGS INDUSTRY ASSESSMENTS
Alzheimer' s Disease Drugs Industry Structure
Market Size
Market Growth Drivers
Alzheimer' s Disease Drugs Sales Volume
Major Producer Facility Locations and Sales Volume
Market Share of Key Producers
Labor Cost
Potential Entrants
Major Distributors
Major Foreign Investments
Technology Development
IV. ALZHEIMER' S DISEASE DRUGS PRODUCTION AND DEMAND
Overview
Demand of Alzheimer' s Disease Drugs by Region
Alzheimer' s Disease Drugs Sales Volume
Ginkgo Bilota Extract
Breviscapine
Ganglioside
Donepezil
Galanthamine
Nicergoline
Rivastigmine
Memantine
Huperzine A
Oxiracetam
Flunarizine
Piracetam
Other Alzheimer' s Disease Drugs
Alzheimer' s Disease Drugs Imports
Ginkgo Bilota Extract Imports
Breviscapine Imports
Ganglioside Imports
Donepezil Imports
Galanthamine Imports
Nicergoline Imports
Rivastigmine Imports
Memantine Imports
Huperzine A Imports
Oxiracetam Imports
Flunarizine Imports
Piracetam Imports
Other Alzheimer' s Disease Drugs Imports
Pricing Trend
V. ALZHEIMER' S DISEASE DRUGS MARKET OUTLOOK
Alzheimer' s Disease Drugs Markets Outlook Overview
Government Regulations
Health Care Insurance Industry Overview
Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits
VI. MARKETING STRATEGIES
China Market Entry Overview
China' s Distribution System
Alzheimer' s Disease Drugs Distribution Channels
Transportation and Freight Infrastructure
Communications
China' s Market Entry
Export to China
Indirect export
Direct Export
License and Contract Manufacture
Assembling in China
Contract Manufacturing
Trade Permit
Investment
Equity Joint Venture
Contractual Joint Venture
Wholly Foreign-Owned Enterprise
VII. ALZHEIMER' S DISEASE DRUGS PRODUCER DIRECTORY
Major Alzheimer' s Disease Drugs Producer Profiles
Distributors and Trading Companies
Associations and Research Institutes
Major End-Users
LIST OF TABLES
I. INTRODUCTION
Economic Outlook Summary
II. BUSINESS ENVIRONMENT
Key Economic Indicators
Industrial Output
Population and Labor Force Trends
Foreign Investment and Loans
Foreign Trade
III. ALZHEIMER' S DISEASE DRUGS INDUSTRY ASSESSMENTS
Alzheimer' s Disease Drugs Sales Volume
Major Producer Facility Locations
Major Alzheimer' s Disease Drugs Producer Sales Volume
Market Share of Key Producers
Major Foreign Investments
IV. ALZHEIMER' S DISEASE DRUGS PRODUCTION AND DEMAND
Total Alzheimer' s Disease Drugs Sales Volume
Alzheimer' s Disease Drugs Major Producer and Their Market Share
Ginkgo Bilota Extract Major Producer and Their Market Share
Breviscapine Major Producer and Their Market Share
Ganglioside Major Producer and Their Market Share
Donepezil Major Producer and Their Market Share
Galanthamine Major Producer and Their Market Share
Dihydroergotamine Major Producer and Their Market Share
Rivastigmine Major Producer and Their Market Share
Memantine Major Producer and Their Market Share
Huperzine A Major Producer and Their Market Share
Oxiracetam Major Producer and Their Market Share
Flunarizine Major Producer and Their Market Share
Piracetam Major Producer and Their Market Share
Alzheimer' s Disease Drugs Import
V. ALZHEIMER' S DISEASE DRUGS MARKET OUTLOOK
Consumer Spending Trend
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits
LIST OF CHARTS
I. NTRODUCTION
Alzheimer' s Disease Drugs Sales Volume
II. BUSINESS ENVIRONMENT
China' s GDP and Industrial Output
Industrial Output by Ownership
China' s Imports and Exports
III. ALZHEIMER' S DISEASE DRUGS INDUSTRY ASSESSMENTS
Alzheimer' s Disease Drugs Sales Volume
IV. ALZHEIMER' S DISEASE DRUGS PRODUCTION AND DEMAND
Alzheimer' s Disease Drugs Sales Volume
Worldwide Alzheimer' s Disease Drugs Demand by Region
Ginkgo Bilota Extract Sales Volume and Market Share
Breviscapine Sales Volume and Market Share
Ganglioside Sales Volume and Market Share
Donepezil Sales Volume and Market Share
Galanthamine Sales Volume and Market Share
Dihydroergotamine Sales Volume and Market Share
Rivastigmine Sales Volume and Market Share
Memantine Sales Volume and Market Share
Huperzine A Sales Volume and Market Share
Oxiracetam Sales Volume and Market Share
Flunarizine Sales Volume and Market Share
Piracetam Sales Volume and Market Share
Other Alzheimer' s Disease Drugs Sales volume and market share
Alzheimer' s Disease Drugs Import Volume
Ginkgo Bilota Extract Import Volume and Market Share
Breviscapine Import Volume and Market Share
Ganglioside Import Volume and Market Share
Donepezil Import Volume and Market Share
Galanthamine Import Volume and Market Share
Dihydroergotamine Import Volume and Market Share
Rivastigmine Import Volume and Market Share
Memantine Import Volume and Market Share
Huperzine A Import Volume and Market Share
Oxiracetam Import Volume and Market Share
Flunarizine Import Volume and Market Share
Piracetam Import Volume and Market Share
Other Alzheimer' s Disease Drugs Import Volume and Market Share
Orphan Diseases Therapeutics in CNS to 2017 - Novel Agents such as AMR101 and ACR16 to Provide Treatment Options and Boost the Huntington's Disease Segment
